T45 Labs

We’re excited to welcome Maryam S. to the T45 Labs family as the new Electrical Engineer, Design & Quality at NuevoSono. Maryam brings hands-on experience in PCB design, embedded systems, and RF engineering for medical devices. She has contributed to a wide range of projects, from non-invasive glucose monitoring to neural signal analysis, with a focus on design, testing, and regulatory documentation. She holds a PhD in Electrical Engineering from the University of Texas at El Paso and will play a key role in advancing NuevoSono’s next-generation intravascular imaging platform. Welcome aboard, Maryam.

We’re excited to welcome Jayachandran Ravichandran, CCRP to the T45 Labs team as our new Clinical Trials Manager. Jay brings over a decade of clinical research experience across first-in-human and IDE studies in cardiology, urology, and dermatology. He has led site management and regulatory operations for early-stage programs and worked closely with cross-functional teams to drive studies forward quickly and rigorously. He joins us at a pivotal moment as multiple T45 Labs portfolio companies move toward U.S. early feasibility trials. We're glad to have him on board.

T45 Fund I has officially closed at $25M, oversubscribed. 🔗 Read the full press release here: https://lnkd.in/dA2c8Bxg “The Fund will advance and fuel development and clinical research programs for our growing portfolio of companies, allowing each to achieve critical milestones while located in our new state-of-the-art facility.” — Marwan Berrada-Sounni, Managing Director, T45 Labs T45 Labs manages every stage of device development, collaborating with clinicians to efficiently bring new cardiovascular solutions to market. Advanced NanoTherapies, Inc VahatiCor Inc NuevoSono #MedTech #HealthcareInnovation #Cardiovascular #MedicalDevices #VentureCapital #Startups #Innovation #T45Labs #HealthTech

We cannot imagine progress without the women who lead, innovate, ask hard questions, and push boundaries every day. Today, we celebrate them: the thinkers, builders, and changemakers who shape the future in ways big and small. Happy International Women's Day! #IWD2025 #WomenInSTEM #Womeninmedtech #InternationalWomensDay #WomensHistoryMonth #Grateful

We’re looking for an Executive Assistant to support our CEO and keep things running smoothly. This on-site role in Santa Clara, CA, is perfect for someone highly organized, proactive, and discreet. Head over to t45labs.com/careers for full details and to apply. #hiring #executiveassistant #careers #hr #openposition #t45labs

As our work at T45 Labs expands, so does our team. We're excited to announce two new key roles to support our clinical programs and portfolio companies: - Senior Clinical Research Scientist Design and oversee clinical studies, ensuring accurate data collection and regulatory compliance. Work directly with investigators and clinical teams to execute study protocols. - Senior Clinical Operations Manager Manage day-to-day clinical trial operations, including budgets, timelines, and vendor coordination. Ensure trials meet regulatory standards and run efficiently. Every role will contribute to meaningful projects, and you will work in a team that values collaboration, precision, and purpose. Head to https://lnkd.in/dJsxduKw for the details and to throw your hat in the ring. #HiringNow #JobOpportunity #SeniorClinicalResearch #ClinicalOperations #ClinicalTrialsJobs #HealthcareCareers #ClinicalScience #T45Labs #ClinicalManagementJobs #JoinOurTeam

As we round off 2024, let's look back on the key milestones our portfolio companies reached this year: Advanced NanoTherapies, Inc completed its first-in-human trial for the SirPlux™ Duo Drug-Coated Balloon, delivering positive results that mark an important step toward addressing coronary de novo disease. Preparations for the DYNAMIC DUO I U.S. early feasibility study are now underway. VahatiCor Inc completed its compassionate use study of the A-FLUX Reducer System™, showing favorable results in improving symptoms for patients with coronary microvascular dysfunction (CMD). With plans to initiate the SERRA-I U.S. early feasibility study, we remain optimistic about the potential to provide relief to patients with few or no options. NuevoSono is preparing for its First-in-Man trial for a next-generation wireless imaging system aimed at simplifying intravascular imaging with improved ease of use and clarity. Heading into 2025, we remain focused and inspired by the possibilities ahead. Wishing everyone a joyful holiday season and a prosperous new year. Here's to continued progress together! #AdvancedNanoTherapies #DrugCoatedBalloon #CMD #VahatiCor #AFluxReducer #NuevoSono #IntravascularImaging #DCB #Reducertherapy #2024Milestones #2025Goals #T45Labs

This Thanksgiving, we thank everyone who makes our work possible: our talented teams at each portfolio company, trusted partners, and supportive community. Your dedication and collaboration drive the progress we're making together in healthcare innovation, creating solutions that truly make a difference. For that, we are deeply grateful. As you gather with loved ones to celebrate, know that we're wishing you a holiday filled with warmth, gratitude, and joy. From all of us at T45 Labs: Happy Thanksgiving! #happythanksgiving #thanksgiving2024 #medtech #gratitude

We're delighted to announce that Angela Mallery, Ed.D., has joined T45 Labs as Vice President of Regulatory and Quality Affairs. With over 30 years of experience in global regulatory strategy and quality compliance, Angela has an exceptional track record guiding medical device approvals across cardiovascular, orthopedic, and neurology sectors. She brings deep expertise in FDA submissions, regulatory audits, and building high-performing teams, skills that make her an invaluable addition to our companies. We're thrilled to have her on board. Welcome, Angela!   #Leadership #TeamAnnouncement #RegulatoryAffairs #QualityAssurance #MedicalDevices #HealthcareInnovation #MedTech #WelcomeToTheTeam